Post-transplant ischemic injury is associated with up-regulated AlloMap gene expression

Clinical Transplantation

Volumn 21, Issue 4, 2007, Pages 523-525

  Yamani, M H ^a   Taylor, D O ^a   Haire, C ^a   Smedira, N ^a   Starling, R C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

AlloMap; Heart transplantation; Post transplant ischemic injury

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; EVEROLIMUS; MATRIX METALLOPROTEINASE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; THROMBOPLASTIN; VITRONECTIN RECEPTOR;

ADULT; AGED; ARTICLE; CARDIAC GRAFT REJECTION; CARDIOVASCULAR DISEASE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GRAFT RECIPIENT; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MULTIPLE REGRESSION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SCORING SYSTEM; UPREGULATION;

ADULT; BIOPSY; CORONARY ANGIOGRAPHY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; ISOANTIGENS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; POSTOPERATIVE COMPLICATIONS; STROKE VOLUME; UP-REGULATION;

EID: 34547446199     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2007.00681.x     Document Type: Article

References (11)

1. Deng MC, Eisen HJ, Mehra RM et al. for the CARGO Investigators. Non-invasive detection of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 2006: 6: 150.
2. Deng MC, Mehra M, Hunt S et al. Leukocyte gene expression signature of CMV viremia in cardiac allograft recipients is distinct from that seen during allograft rejection (abstr). Am J Transplant 2004: 4e (suppl. 8): 455.
3. Starling RC, Deng MC, Kobashigawa JA et al. The influence of corticosteroids on the alloimmune molecular signature for cardiac allograft rejection (abstr). J Heart Lung Transplant 2005: 24: S65.
4. Stewart S, Winters GL, Fishbein MC et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005: 24: 1710. Epub 2005 Jun 20.
5. Yamani MH, Haji SA, Starling RC et al. Myocardial ischemic-fibrotic injury following human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection, and poor long-term outcome. J Am Coll Cardiol 2002: 39: 970.
6. Billingham ME, Baumgartner WA, Watson DC et al. Distant heart procurement for human transplantation. Ultrastructural studies. Circulation 1980: 2: I11.
7. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993: 362: 801.
8. Demetris AJ, Zerbe T, Banner B. Morphology of solid organ allograft arteriopathy: Identification of proliferating intimal cell populations. Transplant Proc 1989: 21: 3667.
9. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest 1983: 49: 327.
10. Yamani MH, Tuzcu EM, Starling RC et al. Myocardial ischemic injury following heart transplantation is associated with upregulation of vitronectin receptor (αvβ3), activation of the matrix metalloproteinase induction system, and subsequent development of coronary vasculopathy. Circulation 2002: 105: 1955.
11. Starling RC, Pharn M, Valantine H et al. Working Group on Molecular Testing in Cardiac Transplantation. Molecular testing in the management of cardiac transplant recipients: Initial clinical experience. J Heart Lung Transplant 2006: 25: 1389.